NTX100 Neuromodulation System - Active

DEVICE2 trials

Sponsors

Noctrix Health, Inc.

Conditions

Restless Legs Syndrome

Unknown Phase

Noninvasive Peripheral Nerve Stimulation for Medication-Refractory Primary RLS (The RESTFUL Study)

CompletedNCT04874155

Noctrix Health, Inc.Restless Legs Syndrome

Start: 2021-05-06End: 2022-04-08Updated: 2024-10-08

Noninvasive Peripheral Nerve Stimulation for Medication-Naive and Medication-Refractory RLS

CompletedNCT05214963

Noctrix Health, Inc.Restless Legs Syndrome

Start: 2022-03-08End: 2023-10-24Updated: 2023-12-15

Related Papers

Acute Effects of Tonic Motor Activation (TOMAC) on Sleep in Adults with Medication-Refractory Restless Legs Syndrome

SLEEP Advances2026-06-11

0704 Comparative Efficacy of Tonic Motor Activation for Medication-Naïve and Dopaminergic-Treated Restless Legs Syndrome

SLEEP2024-04-20

0712 Tonic Motor Activation for Restless Legs Syndrome Is Compatible with Sleep Onset and Reduces Periodic Leg Movements

SLEEP2024-04-20

Long-term efficacy and safety of tonic motor activation for treatment of medication-refractory restless legs syndrome: A 24-Week Open-Label Extension Study

SLEEP2023-07-1311 citations

Efficacy and safety of tonic motor activation (TOMAC) for medication-refractory restless legs syndrome: a randomized clinical trial

SLEEP2023-07-1217 citations